2.9. Analysis.

Comparison 2 Conventional doxorubicin versus liposomalāencapsulated doxorubicin (myocet), Outcome 9 Adverse effects: neutropenic fever (fever >=38, neutropenia grade 4, IV antibiotics and/or hospitalisation).

Comparison 2 Conventional doxorubicin versus liposomalāencapsulated doxorubicin (myocet), Outcome 9 Adverse effects: neutropenic fever (fever >=38, neutropenia grade 4, IV antibiotics and/or hospitalisation).